Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


141 results found


Leukemia, other

MM1YA-CTG01, Ph2, Open, Randomized, Venetoclax + chemotherapy, AML

Primary Objective: To compare the rates of undetectable measurable residual disease (MRD) in patients who achieve a Complete Remission (CR) after induction therapy with 7 +3 (cytarabine + daunorubicin) vs. azacitidine + venetoclax vs. 7+3 + ...